Double-blind, Randomized, Controlled Trial of EPI-743 in Friedreich’s Ataxia. Neurodegnerative Disease Management
Kelly L. Sullivan
Part of the Public Health Commons
Works by Susan Perlman in Public Health
2021
2018
Comprehensive Systematic Review Summary: Treatment of Cerebellar Motor Dysfunction and Ataxia
Kelly L. Sullivan
EPI-743 (Alpha-Tocotrienol Quinone) Demonstrates Long-Term Improvement in Neurological Function and Disease Progression in Friedreich’s Ataxia
Kelly L. Sullivan
EPI-743 (Alpha-Tocotrienol Quinone) Demonstrates Long-Term Improvement in Neurological Function and Disease Progression in Friedreich’s Ataxia
Kelly L. Sullivan